Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT00051311
What this trial is testing

Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers

Who this might be right for
Hematologic Neoplasms
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT01086735
What this trial is testing

Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Assistance Publique - Hôpitaux de Paris 11
Not applicableStudy completedNCT00741455
What this trial is testing

Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Dartmouth-Hitchcock Medical Center 18
Not applicableLooking for participantsNCT05379738
What this trial is testing

Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy

Who this might be right for
Haematological Malignancy
Centre Hospitalier Universitaire de Nice 75
Testing effectiveness (Phase 2)Study completedNCT02458235
What this trial is testing

Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoid LeukemiaJuvenile Myelomonocytic Leukemia+1 more
University of California, San Francisco 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819396
What this trial is testing

Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+11 more
Fred Hutchinson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00506857
What this trial is testing

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 82
Large-scale testing (Phase 3)Study completedNCT04260698
What this trial is testing

Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

Who this might be right for
Hematological Malignancies
Gamida Cell ltd 36
Early research (Phase 1)Active Not RecruitingNCT04177004
What this trial is testing

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientHematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 52
Testing effectiveness (Phase 2)Ended earlyNCT00579111
What this trial is testing

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Who this might be right for
Myelodysplastic and Myeloproliferative DisordersAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Baylor College of Medicine 4
Testing effectiveness (Phase 2)UnknownNCT00129155
What this trial is testing

MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesAllogeneic Transplantation
Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Study completedNCT00824993
What this trial is testing

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 78
Testing effectiveness (Phase 2)Looking for participantsNCT04282187
What this trial is testing

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Acute Myeloid LeukemiaEssential ThrombocythemiaMyelodysplastic Syndrome+6 more
University of Washington 25
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Testing effectiveness (Phase 2)UnknownNCT05084027
What this trial is testing

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Who this might be right for
Hematologic MalignancyOlder PatientsAllogeneic Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University 50
Testing effectiveness (Phase 2)Study completedNCT02661035
What this trial is testing

Allo HSCT Using RIC for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 156
Testing effectiveness (Phase 2)Study completedNCT01810588
What this trial is testing

Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

Who this might be right for
Hematologic Malignancies
Weill Medical College of Cornell University 270
Next Page